It is also reported that ALDH1, CXCR4, and CD133 are well-known markers of highly aggressive, drug-resistant, invasive, and cancer stem cell phenotypes [50,51], suggesting that our KU-CSLCs are highly aggressive and drug-resistant cancer stem cell-like cells. This evidence concerns the gene CXCR4 and cancer.